Report Detail
Global (United States, European Union and China) Biological Drugs Market Research Report 2019-2025
- RnM3579382 |
- 22 July, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.
The world biological drugs market is predicted to gain momentum with rising prevalence of chronic diseases such as cancer and diabetes across the globe. Demand for biological drugs could swell with the expansion of geriatric population at the global level. Currently growing inclination toward adoption of personalized medicines and strong research and development efforts taken to introduce new and powerful biological drugs are foretold to set the tone for a significant rise in demand.
In 2019, the market size of Biological Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biological Drugs.
This report studies the global market size of Biological Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Biological Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bristol-Myers Squibb
Eli Lilly
Shire
Pfizer
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Abbott Laboratories
Baxter
Novartis
Biogen
GlaxoSmithKline
Market Segment by Product Type
Therapeutic Protein
Monoclonal Antibody
Vaccine
Market Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Biological Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Biological Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Biological Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Biological Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Therapeutic Protein
- 1.3.3 Monoclonal Antibody
- 1.3.4 Vaccine
- 1.4 Market Segment by Application
- 1.4.1 Global Biological Drugs Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Ambulatory Surgical Centers
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Biological Drugs Market Size
- 2.1.1 Global Biological Drugs Revenue 2014-2025
- 2.1.2 Global Biological Drugs Sales 2014-2025
- 2.2 Biological Drugs Growth Rate by Regions
- 2.2.1 Global Biological Drugs Sales by Regions 2014-2019
- 2.2.2 Global Biological Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Biological Drugs Sales by Manufacturers
- 3.1.1 Biological Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Biological Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Biological Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Biological Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Biological Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Biological Drugs Price by Manufacturers
- 3.4 Key Manufacturers Biological Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Biological Drugs Market
- 3.6 Key Manufacturers Biological Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Therapeutic Protein Sales and Revenue (2014-2019)
- 4.1.2 Monoclonal Antibody Sales and Revenue (2014-2019)
- 4.1.3 Vaccine Sales and Revenue (2014-2019)
- 4.2 Global Biological Drugs Sales Market Share by Type
- 4.3 Global Biological Drugs Revenue Market Share by Type
- 4.4 Biological Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Biological Drugs Sales by Application
6 United States
- 6.1 United States Biological Drugs Breakdown Data by Company
- 6.2 United States Biological Drugs Breakdown Data by Type
- 6.3 United States Biological Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Biological Drugs Breakdown Data by Company
- 7.2 European Union Biological Drugs Breakdown Data by Type
- 7.3 European Union Biological Drugs Breakdown Data by Application
8 China
- 8.1 China Biological Drugs Breakdown Data by Company
- 8.2 China Biological Drugs Breakdown Data by Type
- 8.3 China Biological Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Biological Drugs Breakdown Data by Company
- 9.2 Rest of World Biological Drugs Breakdown Data by Type
- 9.3 Rest of World Biological Drugs Breakdown Data by Application
- 9.4 Rest of World Biological Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Biological Drugs Sales by Countries
- 9.4.2 Rest of World Biological Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Bristol-Myers Squibb
- 10.1.1 Bristol-Myers Squibb Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Biological Drugs
- 10.1.4 Biological Drugs Product Introduction
- 10.1.5 Bristol-Myers Squibb Recent Development
- 10.2 Eli Lilly
- 10.2.1 Eli Lilly Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Biological Drugs
- 10.2.4 Biological Drugs Product Introduction
- 10.2.5 Eli Lilly Recent Development
- 10.3 Shire
- 10.3.1 Shire Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Biological Drugs
- 10.3.4 Biological Drugs Product Introduction
- 10.3.5 Shire Recent Development
- 10.4 Pfizer
- 10.4.1 Pfizer Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Biological Drugs
- 10.4.4 Biological Drugs Product Introduction
- 10.4.5 Pfizer Recent Development
- 10.5 Amgen
- 10.5.1 Amgen Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Biological Drugs
- 10.5.4 Biological Drugs Product Introduction
- 10.5.5 Amgen Recent Development
- 10.6 F. Hoffmann-La Roche
- 10.6.1 F. Hoffmann-La Roche Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Biological Drugs
- 10.6.4 Biological Drugs Product Introduction
- 10.6.5 F. Hoffmann-La Roche Recent Development
- 10.7 Johnson & Johnson
- 10.7.1 Johnson & Johnson Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Biological Drugs
- 10.7.4 Biological Drugs Product Introduction
- 10.7.5 Johnson & Johnson Recent Development
- 10.8 Merck
- 10.8.1 Merck Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Biological Drugs
- 10.8.4 Biological Drugs Product Introduction
- 10.8.5 Merck Recent Development
- 10.9 Abbott Laboratories
- 10.9.1 Abbott Laboratories Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Biological Drugs
- 10.9.4 Biological Drugs Product Introduction
- 10.9.5 Abbott Laboratories Recent Development
- 10.10 Baxter
- 10.10.1 Baxter Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Biological Drugs
- 10.10.4 Biological Drugs Product Introduction
- 10.10.5 Baxter Recent Development
- 10.11 Novartis
- 10.12 Biogen
- 10.13 GlaxoSmithKline
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Biological Drugs Sales Channels
- 11.2.2 Biological Drugs Distributors
- 11.3 Biological Drugs Customers
12 Market Forecast
- 12.1 Global Biological Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Biological Drugs Sales Forecast by Type
- 12.3 Global Biological Drugs Sales Forecast by Application
- 12.4 Biological Drugs Forecast by Regions
- 12.4.1 Global Biological Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Biological Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Biological Drugs. Industry analysis & Market Report on Biological Drugs is a syndicated market report, published as Global (United States, European Union and China) Biological Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Biological Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
